Phantom Neuro Partners with Amputee Coalition to Foster Innovation in Limb Loss Support#United_States#Austin#Phantom_Neuro#Limb_Loss#Amputee_Coalition
Phantom Neuro Partners with Amputee Coalition to Foster Innovation in Limb Loss Support
Phantom Neuro joins forces with the Amputee Coalition, enhancing support for over 5.6 million Americans living with limb loss and advocating for innovative solutions.
third-news.com
September 29, 2026 at 3:09 PM
Phantom Neuro Partners with Amputee Coalition to Foster Innovation in Limb Loss Support#United_States#Austin#Phantom_Neuro#Limb_Loss#Amputee_Coalition
Phantom Neuro Gains Approval for Groundbreaking Human Clinical Trial of Prosthetic Control System#Australia#Melbourne#Phantom_Neuro#Prosthetic_Control#CYBORG_study
Phantom Neuro Gains Approval for Groundbreaking Human Clinical Trial of Prosthetic Control System
Phantom Neuro has received approval for its first human clinical study in Australia, advancing its prosthetic control technology aimed at improving lives of amputees.
third-news.com
April 15, 2026 at 2:13 PM
Phantom Neuro Gains Approval for Groundbreaking Human Clinical Trial of Prosthetic Control System#Australia#Melbourne#Phantom_Neuro#Prosthetic_Control#CYBORG_study
Phantom Neuro Launches Patient Registry to Empower Amputees with Future Clinical Trials#Phantom_Neuro#Neural_Interface#Prosthetic_Control
Phantom Neuro Launches Patient Registry to Empower Amputees with Future Clinical Trials
The newly opened Patient Registry by Phantom Neuro aims to connect amputees with upcoming clinical opportunities, enhancing prosthetic control advancements.
third-news.com
November 24, 2025 at 7:09 PM
Phantom Neuro Launches Patient Registry to Empower Amputees with Future Clinical Trials#Phantom_Neuro#Neural_Interface#Prosthetic_Control
Phantom Neuro CEO Connor Glass to Showcase Innovations at BioFuture 2025#United_States#New_York#Phantom_Neuro#Connor_Glass#BioFuture_2025
Phantom Neuro CEO Connor Glass to Showcase Innovations at BioFuture 2025
Join Dr. Connor Glass, CEO of Phantom Neuro, as he presents groundbreaking advancements in human-machine interfaces at BioFuture 2025 in NYC.
third-news.com
October 8, 2025 at 6:14 PM
Phantom Neuro CEO Connor Glass to Showcase Innovations at BioFuture 2025#United_States#New_York#Phantom_Neuro#Connor_Glass#BioFuture_2025
Phantom Neuro Closes $19M Series A to Boost Neural Tech in Prosthetics and Robotics#USA#Austin#Phantom_Neuro#Ottobock#Neural_Interface
Phantom Neuro Closes $19M Series A to Boost Neural Tech in Prosthetics and Robotics
Phantom Neuro announces $19 million in Series A funding led by Ottobock. The funds will accelerate clinical trials and enhance its prosthetic technology.
third-news.com
April 15, 2025 at 2:11 PM
Phantom Neuro Closes $19M Series A to Boost Neural Tech in Prosthetics and Robotics#USA#Austin#Phantom_Neuro#Ottobock#Neural_Interface
Phantom Neuro's FDA Breakthrough Recognition Enhances Neurotech Innovation for Mobility Solutions#USA#Austin#Neurotechnology#FDA_Breakthrough#Phantom_Neuro
Phantom Neuro's FDA Breakthrough Recognition Enhances Neurotech Innovation for Mobility Solutions
Phantom Neuro achieves FDA Breakthrough Device and TAP Designations, reinforcing its position in neurotechnology for intuitive mobility solutions.
third-news.com
March 6, 2025 at 2:50 PM
Phantom Neuro's FDA Breakthrough Recognition Enhances Neurotech Innovation for Mobility Solutions#USA#Austin#Neurotechnology#FDA_Breakthrough#Phantom_Neuro